Sabine Willems,Vasily Morozov,Julian A Marschner,Daniel Merk
{"title":"Comparative Profiling and Chemogenomics Application of Chemical Tools for NR4A Nuclear Receptors.","authors":"Sabine Willems,Vasily Morozov,Julian A Marschner,Daniel Merk","doi":"10.1021/acs.jmedchem.5c00459","DOIUrl":null,"url":null,"abstract":"The ligand-activated transcription factors of the NR4A family are implicated as promising drug targets with neuroprotective and anticancer potential and attract strong attention in drug discovery. Several NR4A modulators have been described, but a validated set of direct ligands for biological studies is lacking. Here, we profiled the reported and commercially available agonists and inverse agonists under uniform conditions in several orthogonal test systems to establish a highly annotated tool and gain comprehensive insights into the NR4A modulator characteristics. This comparative profiling revealed a lack of on-target binding and modulation for several putative NR4A ligands and validated a set of chemically diverse compounds as direct NR4A modulators for chemogenomics-based target identification studies. Prospective applications unveiled roles of NR4A receptors in endoplasmic reticulum stress and adipocyte differentiation, demonstrating suitability of the set to link the orphan targets with phenotypic effects.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"6 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.5c00459","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
The ligand-activated transcription factors of the NR4A family are implicated as promising drug targets with neuroprotective and anticancer potential and attract strong attention in drug discovery. Several NR4A modulators have been described, but a validated set of direct ligands for biological studies is lacking. Here, we profiled the reported and commercially available agonists and inverse agonists under uniform conditions in several orthogonal test systems to establish a highly annotated tool and gain comprehensive insights into the NR4A modulator characteristics. This comparative profiling revealed a lack of on-target binding and modulation for several putative NR4A ligands and validated a set of chemically diverse compounds as direct NR4A modulators for chemogenomics-based target identification studies. Prospective applications unveiled roles of NR4A receptors in endoplasmic reticulum stress and adipocyte differentiation, demonstrating suitability of the set to link the orphan targets with phenotypic effects.
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.